Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Lynne Shallcross/KHN illustration; Getty Images
Secretive ‘Rebate Trap’ Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
Patients are often forced into using brand names because drug formularies favor them over cheaper competitors.
County By County, Researchers Link Opioid Deaths To Drugmakers’ Marketing
A JAMA study looking at county-specific federal data finds that the more opioid-related marketing dollars spent in a county, the higher rates of doctors who prescribed those drugs, and ultimately, more overdose deaths.
Furloughed Feds’ Health Coverage Intact, But Shutdown Still Complicates Things
Some federal employees face insurance paperwork glitches that affect their health coverage and add pressure to the stress of going without pay.
Pain From The Government Shutdown Spreads. This Time It’s Food Stamps
Food stamps for February are being distributed about two weeks early because officials say the federal money to pay for them won’t be available later due to the government shutdown. State and local officials are scratching their heads about what might happen in March if the impasse continues.
Why Older Adults Should Eat More Protein (And Not Overdo Protein Shakes)
The Electronics Industry Sees Money In Your Health
GoFundMe CEO: ‘Gigantic Gaps’ In Health System Showing Up In Crowdfunding
Patients Turn To GoFundMe When Money And Hope Run Out
Call The Midwife! (If The Doctor Doesn’t Object)
Providers Walk ‘Fine Line’ Between Informing And Scaring Immigrant Patients
California’s Top Lawyer Cements His Role As Health Care Defender-In-Chief
Meth’s Resurgence Spotlights Lack Of Meds To Combat The Addiction
'Something that was supposed to help him hurt him'
Heidi de Marco/KHN
Tainted Drugs
When Medicine Makes Patients Sicker
The Food and Drug Administration is supposed to inspect all factories, foreign and domestic, that produce drugs for the U.S. market. But a KHN review of thousands of FDA documents — inspection records, recalls, warning letters and lawsuits — reveals how drugs that are poorly manufactured or contaminated can reach consumers.
Sign Up For Our Email Newsletter
Stay informed by signing up for the KHN Morning Briefing and other emails:
